+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Dosage (Fixed, Variable), By Application, And Segment Forecasts, 2018 - 2025

  • ID: 4661527
  • Report
  • 108 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Astra Zeneca
  • Eli Lilly And Company
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Novartis AG
  • Novo Nordisk A/S
  • MORE
The global injection pens/injectable pens/pen injectors market is expected to reach USD 67.9 billion by 2025, registering a 9.4% CAGR during the forecast period. High demand for these devices for management of various chronic as well as acute diseases and increasing awareness in developing regions are key factors expected to drive the market.

Injectable pens have witnessed significant success in improving patient convenience during management of chronic disease, a process that might include administering intermittent injections. These devices are more convenient and affordable than other delivery systems. Ongoing studies on the same to assess their applications in management of other diseases, including but not limited to Hepatitis C and cancer, is expected to ensure swift market growth through 2025.

Further key findings from the study suggest:
  • Rising incidence of diseases such as diabetes and arthritis is primarily boosting market growth
  • Increase in government healthcare expenditure and availability of favorable healthcare insurance policies in developed as well as developing countries is driving the market
  • By product, reusable injectable pens are the largest and fastest growing segment owing to the advantages associated with them such as cost effectiveness and patient convenience. Commercially available reusable injectable pens mainly include Novopen, Luxura, Berlipen, AllStar, NovoRapid, basalgar, Bydureon, Epipen and Genotropin
  • By dosage, variable dosage is the fastest growing segment. Some of the customizable variable pens are UnoPen, ServoPen and Ypsopen by Ypsomed, Madie by SHL Group, and Evo pen by Copernicus
  • North America dominates the market, followed by Europe. Technological advancements and increase in incidence of osteoporosis, arthritis, and anaphylaxis are factors that can be attributable to its largest market share
  • Asia Pacific is expected to be the fastest growing region over the forecast period. Better accessibility to healthcare, coupled with constantly increasing healthcare expenditure in the region, is fueling market growth
  • China is one of the most lucrative markets with tremendous growth opportunities for global as well as local players. This is owing to favorable factors such as availability of labor and raw materials at significantly lower prices as compared to other regions
  • Key players in the market include Owen Mumford Ltd.; GlaxoSmithKline plc; Eli Lilly and Company; Mylan N.V.; AstraZeneca; Novo Nordisk; Sanofi; and Sandoz Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astra Zeneca
  • Eli Lilly And Company
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Novartis AG
  • Novo Nordisk A/S
  • MORE

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
5.1 Market variable Analysis
5.1.1 Increasing Disease Prevalence
5.1.2 Increasing Geographical Reach By Market Players
5.1.3 Increasing Geographical Reach By Market Players
5.1.4 Market Restraint Analysis
5.1.4.1 Slow Approval Procedures
5.1.4.2 Low Awareness And Misconception About Pen Injectors

Chapter 6 Business Environment Analysis
6.1 SWOT Analysis; By factor (political & legal, economic and technological)
6.2 Porter’s five forces analysis

Chapter 7 Product Business Analysis
7.1 Injection Pens Market: Product Movement Analysis
7.1.1 Disposable
7.1.1.1 Disposable Market Estimates And Forecast, 2014 - 2025
7.1.1.2 Reusable
7.1.1.2.1 Reusable Market Estimates And Forecast, 2014 - 2025

Chapter 8 Dosage Business Analysis
8.1 Injection Pens Market: Dosage Movement Analysis
8.1.1 Fixed
8.1.1.1 Fixed Dosage Market Estimates And Forecast, 2014 - 2025
8.1.2 Variable
8.1.2.1 Variable Dosage Market Estimates And Forecast, 2014 - 2025

Chapter 9 Application Business Analysis
9.1 Injection Pens Market: Application Movement Analysis
9.1.1 Diabetes
9.1.1.1 Diabetes Market Estimates And Forecast, 2014 - 2025
9.1.1.2 Insulin
9.1.1.2.1 Insulin Market Estimates And Forecast, 2014 - 2025
9.1.1.3 Non-insulin
9.1.1.3.1 Non Insulin Market Estimates And Forecast, 2014 - 2025
9.1.2 Anaphylaxis
9.1.2.1 Anaphylaxis Market Estimates And Forecast, 2014 - 2025
9.1.3 Osteoporosis
9.1.3.1 Osteoporosis Market Estimates And Forecast, 2014 - 2025
9.1.4 Growth hormone deficiency
9.1.4.1 Growth Hormone Deficiency Market Estimates And Forecast, 2014 - 2025
9.1.5 Arthritis
9.1.5.1 Arthritis Market Estimates And Forecast, 2014 - 2025
9.1.6 Others
9.1.6.1 Others Market Estimates And Forecast, 2014 - 2025

Chapter 10 Regional Business Analysis
10.1 Injection Pens Market: regional Movement Analysis
10.1.1 U.S.
10.1.1.1 North America Market Estimates And Forecast, 2014 - 2025
10.1.1.2 U.S.
10.1.1.2.1 U.S. Market Estimates And Forecast, 2014 - 2025
10.1.1.3 Canada
10.1.1.3.1 Canada Market Estimates And Forecast, 2014 - 2025
10.1.2 Europe
10.1.2.1 Europe Market Estimates And Forecast, 2014 - 2025
10.1.2.2 Germany
10.1.2.2.1 Germany Market Estimates And Forecast, 2014 - 2025
10.1.2.3 U.K.
10.1.2.3.1 U.K. Market Estimates And Forecast, 2014 - 2025
10.1.2.4 Greece
10.1.2.4.1 Greece Market Estimates And Forecast, 2014 - 2025
10.1.2.5 Denmark
10.1.2.5.1 Denmark Market Estimates And Forecast, 2014 - 2025
10.1.2.6 Spain
10.1.2.6.1 Spain Market Estimates And Forecast, 2014 - 2025
10.1.2.7 Norway
10.1.2.7.1 Norway Market Estimates And Forecast, 2014 - 2025
10.1.2.8 Belgium
10.1.2.8.1 Belgium Market Estimates And Forecast, 2014 - 2025
10.1.2.9 Austria
10.1.2.9.1 Austria Market Estimates And Forecast, 2014 - 2025
10.1.3 Asia Pacific
10.1.3.1 Asia Pacific Market Estimates And Forecast, 2014 - 2025
10.1.3.2 Japan
10.1.3.2.1 Japan Market Estimates And Forecast, 2014 - 2025
10.1.3.3 China
10.1.3.3.1 China Market Estimates And Forecast, 2014 - 2025
10.1.3.4 India
10.1.3.4.1 India Market Estimates And Forecast, 2014 - 2025
10.1.3.5 Thailand
10.1.3.5.1 Thailand Market Estimates And Forecast, 2014 - 2025
10.1.3.6 Australia
10.1.3.6.1 Australia Market Estimates And Forecast, 2014 - 2025
10.1.3.7 Singapore
10.1.3.7.1 Singapore Market Estimates And Forecast, 2014 - 2025
10.1.3.8 Malaysia
10.1.3.8.1 Malaysia Market Estimates And Forecast, 2014 - 2025
10.1.3.9 Srilanka
10.1.3.9.1 Srilanka Market Estimates And Forecast, 2014 - 2025
10.1.3.10 Bangladesh
10.1.3.10.1 Bangladesh Market Estimates And Forecast, 2014 - 2025
10.1.3.11 South Korea
10.1.3.11.1 Southkorea Market Estimates And Forecast, 2014 - 2025
10.1.4 Latin America
10.1.4.1 Latin America Market Estimates And Forecast, 2014 - 2025
10.1.4.2 Brazil
10.1.4.2.1 Brazil Market Estimates And Forecast, 2014 - 2025
10.1.4.3 Mexico
10.1.4.3.1 Mexico Market Estimates And Forecast, 2014 - 2025
10.1.4.4 Argentina
10.1.4.4.1 Argentina Market Estimates And Forecast, 2014 - 2025
10.1.5 Middle East & Africa
10.1.5.1 Middle East And Africa Market Estimates And Forecast, 2014 - 2025
10.1.5.2 UAE
10.1.5.2.1 UAE Market Estimates And Forecast, 2014 - 2025
10.1.5.3 Saudi Arabia
10.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2014 - 2025
10.1.5.4 South Africa
10.1.5.4.1 South Africa Market Estimates And Forecast, 2014 - 2025
10.1.5.5 Qatar
10.1.5.5.1 Qatar Market Estimates And Forecast, 2014 - 2025
10.1.5.6 Kuwait
10.1.5.6.1 Kuwait Market Estimates And Forecast, 2014 - 2025

Chapter 11 Company Profile
11.1 Owen Mumenford Ltd
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 Eli Lilly And Company
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 GlaxoSmithKline plc
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Mylan N.V.
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 Astra Zeneca
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 product BENCHMARKING
11.6 Novo Nordisk A/S
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 Novartis AG
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.8 Sanofi
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.8.4 Strategic Initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 3 North America Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 4 North America Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 5 North America Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 6 U.S. Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 7 U.S. Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 8 U.S. Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 9 U.S. Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 10 Canada Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 11 Canada Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 12 Canada Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 13 Canada Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 14 Europe Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 15 Europe Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 16 Europe Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 17 Europe Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 18 Austria Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 19 Austria Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 20 Austria Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 21 Austria Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 22 Denmark Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 23 Denmark Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 24 Denmark Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 25 Denmark Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 26 Belgium Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 27 Belgium Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 28 Belgium Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 29 Belgium Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 30 U.K. Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 31 U.K. Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 32 U.K. Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 33 U.K. Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 34 Greece Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 35 Greece Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 36 Greece Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 37 Greece Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 38 Germany Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 39 Germany Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 40 Germany Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 41 Germany Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 42 Spain Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 43 Spain Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 44 Spain Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 45 Spain Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 46 Norway Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 47 Norway Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 48 Norway Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 49 Norway Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 50 Asia Pacific Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 51 Asia Pacific Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 52 Asia Pacific Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 53 Asia Pacific Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 54 India Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 55 India Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 56 India Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 57 India Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 58 China Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 59 China Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 60 China Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 61 China Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 62 Japan Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 63 Japan Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 64 Japan Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 65 Japan Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 66 Australia Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 67 Australia Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 68 Australia Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 69 Australia Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 70 Singapore Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 71 Singapore Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 72 Singapore Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 73 Singapore Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 74 South Korea Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 75 South Korea Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 76 South Korea Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 77 South Korea Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 78 Srilanka Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 79 Srilanka Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 80 Srilanka Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 81 Srilanka Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 82 Bangladesh Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 83 Bangladesh Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 84 Bangladesh Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 85 Bangladesh Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 86 Thailand Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 87 Thailand Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 88 Thailand Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 89 Thailand Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 90 Malaysia Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 91 Malaysia Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 92 Malaysia Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 93 Malaysia Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 94 Latin America Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 95 Latin America Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 96 Latin America Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 97 Latin America Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 98 Brazil Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 99 Brazil Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 100 Brazil Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 101 Brazil Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 102 Argentina Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 103 Argentina Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 104 Argentina Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 105 Argentina Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 106 Mexico Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 107 Mexico Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 108 Mexico Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 109 Mexico Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 110 MEA Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 111 MEA Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 112 MEA Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 113 MEA Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 114 UAE Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 115 UAE Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 116 UAE Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 117 UAE Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 118 Saudi Arabia Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 119 Saudi Arabia Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 120 Saudi Arabia Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 121 Saudi Arabia Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 122 South Africa Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 123 South Africa Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 124 South Africa Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 125 South Africa Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 126 Kuwait Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 127 Kuwait Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 128 Kuwait Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 129 Kuwait Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)
Table 130 Qatar Injection Pens Market, By Product, 2014 - 2025 (USD millions)
Table 131 Qatar Injection Pens Market, By Dosage, 2014 - 2025 (USD millions)
Table 132 Qatar Injection Pens Market , By Application, 2014 - 2025 (USD millions)
Table 133 Qatar Injection Pens Market, By Ingredient, 2014 - 2025 (USD millions)

List of Figures

Fig.1 Injection Penssystems market snapshot
Fig.2 Injection Penssystems market segmentation
Fig.3 Injection Pens market driver impact
Fig.4 Injection Pens market driver impact
Fig.5 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig.6 Porter’s Five Forces Analysis
Fig.7 Injection Pens market: Product outlook and key takeaways
Fig.8 Injection Pens Product Movement Analysis
Fig.9 Disposable market estimates and forecast, 2014 - 2025
Fig.10 Reusable market estimates and forecast, 2014 - 2025
Fig.11 Injection Pens market: Dosage outlook and key takeaways
Fig.12 Injection Pens Analysis Market: Type Movement Analysis
Fig.13 Fixed dosage market estimates and forecast, 2014 - 2025
Fig.14 Variable Dosage market estimates and forecast, 2014 - 2025
Fig.15 Injection Pens market: End-user outlook and key takeaways
Fig.16 Injection Pens Market: Application Movement Analysis
Fig.17 Diabetes market estimates and forecast, 2014 - 2025
Fig.18 Insulin market estimates and forecast, 2014 - 2025
Fig.19 Non Insulin market estimates and forecast, 2014 - 2025
Fig.20 Anaphlaxis market estimates and forecast, 2014 - 2025
Fig.21 Osteoporosis market estimates and forecast, 2014 - 2025
Fig.22 Growth hormone deficiency market estimates and forecast, 2014 - 2025
Fig.23 Arthritis market estimates and forecast, 2014 - 2025
Fig.24 Others market estimates and forecast, 2014 - 2025
Fig.25 Injection Pens market: regional outlook and key takeaways
Fig.26 Injection Pens Market: Regional Movement Analysis
Fig.27 U.S.
Fig.28 North America market estimates and forecast, 2014 - 2025
Fig.29 U.S. market estimates and forecast, 2014 - 2025
Fig.30 Canada market estimates and forecast, 2014 - 2025
Fig.31 Europe
Fig.32 Europe market estimates and forecast, 2014 - 2025
Fig.33 Germany market estimates and forecast, 2014 - 2025
Fig.34 U.K. market estimates and forecast, 2014 - 2025
Fig.35 Greece market estimates and forecast, 2014 - 2025
Fig.36 Denmark market estimates and forecast, 2014 - 2025
Fig.37 Spain market estimates and forecast, 2014 - 2025
Fig.38 Norway market estimates and forecast, 2014 - 2025
Fig.39 Belgium market estimates and forecast, 2014 - 2025
Fig.40 Austria market estimates and forecast, 2014 - 2025
Fig.41 Asia-Pacific
Fig.42 Asia-Pacific market estimates and forecast, 2014 - 2025
Fig.43 Japan market estimates and forecast, 2014 - 2025
Fig.44 China market estimates and forecast, 2014 - 2025
Fig.45 India market estimates and forecast, 2014 - 2025
Fig.46 Thailand market estimates and forecast, 2014 - 2025
Fig.47 Australia market estimates and forecast, 2014 - 2025
Fig.48 Singapore market estimates and forecast, 2014 - 2025
Fig.49 Malaysia market estimates and forecast, 2014 - 2025
Fig.50 Sri Lanka market estimates and forecast, 2014 - 2025
Fig.51 Bangladesh market estimates and forecast, 2014 - 2025
Fig.52 South Korea market estimates and forecast, 2014 - 2025
Fig.53 Latin America
Fig.54 Latin America market estimates and forecast, 2014 - 2025
Fig.55 Brazil market estimates and forecast, 2014 - 2025
Fig.56 Mexico market estimates and forecast, 2014 - 2025
Fig.57 Argentina market estimates and forecast, 2014 - 2025
Fig.58 Middle East & Africa
Fig.59 Middle east market estimates and forecast, 2014 - 2025
Fig.60 UAE market estimates and forecast, 2014 - 2025
Fig.61 Saudi Arabia market estimates and forecast, 2014 - 2025
Fig.62 South Africa market estimates and forecast, 2014 - 2025
Fig.63 Qatar market estimates and forecast, 2014 - 2025
Fig.64 Kuwait market estimates and forecast, 2014 - 2025
Fig.65 Company Profile

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Owen Mumenford Ltd
  • Eli Lilly And Company
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Astra Zeneca
  • Novo Nordisk A/S
  • Novartis AG
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4661527
Adroll
adroll